Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features
Journal: Cancer Research
Published: 2020-02-15
DOI: 10.1158/0008-5472.can-19-1633
Affiliations: 15
Go to articleJournal: Cancer Research
Published: 2020-02-15
DOI: 10.1158/0008-5472.can-19-1633
Affiliations: 15
Go to article